Herpes Simplex and HIV Infections and Preterm PROM

Maternal human immunodeficiency virus (HIV) and genital herpes simplex virus (HSV) infection in pregnancy have potential for vertical transmission that may result in death or morbidity. The risk increases with preterm delivery and prolonged ruptured membranes. When managing preterm premature rupture of membranes, the risk of transmission must be weighed against the risk of prematurity. Before 32 to 34 weeks, expectant management is preferred for patients with well controlled HIV or recurrent active genital HSV infection. For patients with advanced HIV disease or primary genital HSV infection, the risk of vertical transmission is higher and many clinical factors need to be considered.

[1]  A. Bardeguez,et al.  Preterm premature rupture of membranes in pregnancies complicated by human immunodeficiency virus infection: A single center's five-year experience , 2007, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[2]  M. Lin,et al.  Preterm Premature Rupture of Membranes in Human Immunodeficiency Virus-Infected Women: A Novel Case Series , 2006, Infectious diseases in obstetrics and gynecology.

[3]  A. Wald,et al.  Genital herpes complicating pregnancy. , 1998, Obstetrics and gynecology.

[4]  Jean R. Anderson,et al.  Neonatal outcome following conservative management of PPROM among HIV infected patients , 2004 .

[5]  James B. Hill,et al.  Acyclovir Prophylaxis to Prevent Herpes Simplex Virus Recurrence at Delivery: A Systematic Review , 2003, Obstetrics and gynecology.

[6]  D. Lewis,et al.  Expectant management of preterm premature rupture of membranes complicated by active recurrent genital herpes. , 2003, American journal of obstetrics and gynecology.

[7]  J. Zeh,et al.  Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. , 2003, JAMA.

[8]  P. Napolitano,et al.  Acyclovir treatment of primary herpes in pregnancy complicated by second trimester preterm premature rupture of membranes with term delivery: case report. , 2002, American journal of perinatology.

[9]  L. Mofenson,et al.  Combination Antiretroviral Strategies for the Treatment of Pregnant HIV‐1‐Infected Women and Prevention of Perinatal HIV‐1 Transmission , 2002, Journal of acquired immune deficiency syndromes.

[10]  M. Schluchter,et al.  Duration of ruptured membranes and vertical transmission of HIV-1: a meta-analysis from 15 prospective cohort studies , 2001, AIDS.

[11]  ACOG committee opinion scheduled Cesarean delivery and the prevention of vertical transmission of HIV infection. Number 234, May 2000 (replaces number 219, August 1999). , 2001, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[12]  L. Kalish,et al.  Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. , 1999, The New England journal of medicine.

[13]  R. Steketee,et al.  Distinct risk factors for intrauterine and intrapartum human immunodeficiency virus transmission and consequences for disease progression in infected children. Perinatal AIDS Collaborative Transmission Study. , 1999, The Journal of infectious diseases.

[14]  J. Goedert,et al.  Influence of other maternal variables on the relationship between maternal virus load and mother-to-infant transmission of human immunodeficiency virus type 1. , 1997, The Journal of infectious diseases.

[15]  L. Kalish,et al.  Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child , 1996, The New England journal of medicine.

[16]  S. Kenyon,et al.  Preterm premature rupture of membranes. , 2012, Archivos argentinos de pediatria.

[17]  J. Goedert,et al.  The relationship of the duration of ruptured membranes to vertical transmission of human immunodeficiency virus. , 1996, American journal of obstetrics and gynecology.

[18]  R. Gelber,et al.  Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. , 1994, The New England journal of medicine.

[19]  T. Quinn,et al.  Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors. , 1993, JAMA.

[20]  S. MacGregor Human immunodeficiency virus infection in pregnancy. , 1991, Clinics in perinatology.

[21]  H. Schneider,et al.  Management of primary herpes in pregnancy complicated by ruptured membranes and extreme prematurity: case report. , 1987, Obstetrics and gynecology.

[22]  R. Freeman,et al.  Maternal herpes infection complicated by prolonged premature rupture of membranes. , 1985, American journal of perinatology.